Position in DGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,945,424
+$4,665,894 QoQ
Shares Held
122,183
+10.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026&PARTNERS holds $64,941,307 across 15 Diagnostics & Research names. DGX ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
This page
|
122,183 | $23,945,424 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
26,876 | $13,210,360 | |
| 3 | DHR |
Danaher Corp /De/
|
48,195 | $9,137,772 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
6,326 | $3,554,516 | |
| 5 | LH |
Labcorp Holdings Inc.
|
9,868 | $2,632,881 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
4,360 | $2,093,628 | |
| 7 | WAT |
Waters Corp /De/
|
6,802 | $2,025,635 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
10,802 | $1,842,173 |
All Filings in DGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,945,424 | 122,183 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,279,530 | 111,102 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,251,248 | 101,014 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,107,601 | 89,671 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,327,459 | 25,576 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,162,830 | 27,594 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,809,594 | 11,656 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $624,583 | 4,563 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||